Zimmer Biomet Completes Acquisition of Monogram Technologies, Expands Robotics Portfolio

Zimmer Biomet Holdings, a global medical technology leader, has completed the acquisition of Monogram Technologies Inc., an AI-driven orthopedic robotics company. The transaction creates a broad portfolio of orthopedic robotics and navigation technologies, including a pathway towards fully autonomous robotic technology for orthopedic procedures. Zimmer Biomet's acquisition of Monogram is expected to add new capabilities to its existing suite of technology solutions, making it a leader in the field of orthopedic robotics and navigation.

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has completed the acquisition of Monogram Technologies Inc. (NasdaqCM: MGRM), an AI-driven orthopedic robotics company, for approximately $150 million Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc..^[1]. The acquisition, announced in July 2025, aims to expand Zimmer Biomet's portfolio of orthopedic robotics and navigation technologies, positioning the company as a leader in the field.

Under the terms of the merger agreement, each outstanding share of Monogram common stock will be converted into $4.04 in cash plus non-tradeable contingent value rights worth up to $12.37 if development, regulatory, and revenue milestones are met by 2030. Monogram shares will be delisted from Nasdaq following the transaction Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio^[2].

The acquisition enhances Zimmer Biomet's capabilities in orthopedic robotics, particularly in semi-autonomous and fully autonomous surgical systems. Monogram's surgeon-guided, CT-based systems will complement Zimmer Biomet's existing Rosa Robotics platform and other navigation tools, offering surgeons a broader range of robotic and navigation options.

Zimmer Biomet's CEO, Ivan Tornos, commented, "By bringing Monogram into the Zimmer Biomet innovation ecosystem, we have set a bold course to become the first orthopedic company to offer a fully autonomous robotic solution complementing our current robotic and navigation offerings. We aim to provide surgeons the broadest choice in robotics and navigation across a wide range of procedures and care settings" Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio^[2].

The acquisition is expected to be neutral to adjusted earnings per share in 2025-2027 and accretive thereafter, contributing to revenue growth beginning in 2027. The transaction is funded through a combination of cash on the balance sheet and other available debt financing sources Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc..^[1].